NIH researchers develop AI tool for personalized oncology
- On April 18, 2024, researchers from the National Institutes of Health (NIH) published a proof-of-concept study in Nature Cancer detailing a new artificial intelligence (AI) tool to match patients with the appropriate cancer drug based on their tumor RNA. The tool is called the Personalized Single-Cell Expression-Based for Treatments in Oncology...
More Articles
Discovering 6 applications of bioinformatics in drug repurposing
Northeastern University defines bioinformatics as a combination of computer programming, big data, and biology that can be applied to identify and understand sequences or patterns in healthcare. According to the National Human Genome...Ethical Guidelines, Emerging Regulations in Octopus Research
With their unique biological features, octopuses have become valuable subjects in medical research. Their extraordinary abilities, such as camouflage, regenerative capabilities, and highly developed nervous systems, make them captivating...How to Effectively Integrate AI into Clinical Trials
Since its inception, artificial intelligence (AI) has continually disrupted practices across all industries. As more and more healthcare researchers and clinicians adopt AI, experts have noted the impact of AI on clinical research and...Innovative Tech for Drug Manufacturing: Revolutionizing Pharma
The pharmaceutical industry is no stranger to technological innovation. Over the years, it has seen numerous advancements in drug development, manufacturing processes, and quality control. However, in recent years, the pace of innovation...Expanding Product Portfolios Through Technology Integration
The biotechnology and pharmaceutical industries have long been at the forefront of technological innovation, leveraging cutting-edge advancements to improve healthcare outcomes and enhance product portfolios. In an era where...Sponsored by NTT DATA
